CHICAGO, IL—Extended follow-up of patients with type 2 diabetes and multivessel disease who participated in the FREEDOM trial shows that coronary artery bypass graft surgery retains a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results